ALFREDO HIBBERT: Open Payments
NPI 1427153691 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 19 payments from 7 companies in 2025. Trend: 2023 $995 · 2024 $394 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $269 |
| UCB, Inc. | 3 | $149 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Phadia US Inc. | 1 | $25 |
| HARTMANN USA, INC. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
Products named: REXULTI, DALVANCE, Briviact, EMBLAVEO, AVYCAZ, Nayzilam, ImmunoCAP, ZETUVIT PLUS 10X10 P10.
Industry payments across NV — which companies pay providers there.
